Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-03-07
2010-12-14
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S504000
Reexamination Certificate
active
07851465
ABSTRACT:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine compounds, and structurally and functionally related compounds, and methods of using such compounds as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, hyperproliferation, vascular abnormalities, and the like.
REFERENCES:
patent: 3261828 (1966-07-01), Uskokovic
patent: 3384635 (1968-05-01), Calabateas
patent: 3415814 (1968-12-01), Calabeteas
patent: 3847905 (1974-11-01), Bub
patent: 4076823 (1978-02-01), Wade
patent: 4088756 (1978-05-01), Voorhees
patent: 4108852 (1978-08-01), Bub
patent: 4110337 (1978-08-01), Szarvasi
patent: RE30293 (1980-06-01), Bub
patent: 4495101 (1985-01-01), Klaubert
patent: 4551480 (1985-11-01), Stiefel et al.
patent: 4623646 (1986-11-01), Casals-Stenzel
patent: 4751223 (1988-06-01), Glamkowski
patent: 4820834 (1989-04-01), Evans et al.
patent: 4894366 (1990-01-01), Okuhara
patent: 4898861 (1990-02-01), Morgan
patent: 4916138 (1990-04-01), Ueda
patent: 4929611 (1990-05-01), Okuhara
patent: 4946778 (1990-08-01), Ladner
patent: 5004741 (1991-04-01), Evans
patent: 5041438 (1991-08-01), Hsu
patent: 5141930 (1992-08-01), Nakao
patent: 5216148 (1993-06-01), Klaus
patent: 5288514 (1994-02-01), Ellman
patent: 5324726 (1994-06-01), Bock
patent: 5444092 (1995-08-01), Collins
patent: 5521170 (1996-05-01), Setoi
patent: 5545568 (1996-08-01), Ellman
patent: 5559230 (1996-09-01), Ogawa
patent: 5591227 (1997-01-01), Dinh
patent: 5597915 (1997-01-01), Chambers
patent: 5599352 (1997-02-01), Dinh
patent: 5633251 (1997-05-01), Claremon
patent: 5677282 (1997-10-01), Oleksyszyn
patent: 5697967 (1997-12-01), Dinh
patent: 5763437 (1998-06-01), Sato
patent: 5776946 (1998-07-01), McGeer
patent: 5861380 (1999-01-01), Gyorkos
patent: 5962337 (1999-10-01), Ohlmeyer
patent: 6004942 (1999-12-01), Firestein
patent: 6074859 (2000-06-01), Hirokawa
patent: 6080568 (2000-06-01), Day et al.
patent: 6100254 (2000-08-01), Budde
patent: 6239131 (2001-05-01), Shinozaki
patent: 6277844 (2001-08-01), Spector
patent: 6319931 (2001-11-01), Kroemer
patent: 6506744 (2003-01-01), Alig
patent: 6524623 (2003-02-01), Hodosh
patent: 6524832 (2003-02-01), Kufe
patent: 2457405 (2003-03-01), Glick
patent: 6579854 (2003-06-01), Mitchell
patent: 6605593 (2003-08-01), Naicker
patent: 6613739 (2003-09-01), Naicker
patent: 6767533 (2004-07-01), Casellas
patent: 6824561 (2004-11-01), Soykan
patent: 6916813 (2005-07-01), Atwal
patent: 7125866 (2006-10-01), Glick
patent: 7144880 (2006-12-01), Glick
patent: 7175953 (2007-02-01), Licha
patent: 7220739 (2007-05-01), Glick
patent: 7250410 (2007-07-01), Bourguignon
patent: 7276348 (2007-10-01), Glick
patent: 7351421 (2008-04-01), Bendett
patent: 2002/0025946 (2002-02-01), Buchanan
patent: 2002/0048566 (2002-04-01), El-Deiry
patent: 2002/0128208 (2002-09-01), Snyder
patent: 2003/0044776 (2003-03-01), Dykens
patent: 2003/0119029 (2003-06-01), Glick
patent: 2004/0009972 (2004-01-01), Ding
patent: 2004/0087489 (2004-05-01), Ruiz
patent: 2004/0157833 (2004-08-01), Harris et al.
patent: 2004/0176358 (2004-09-01), Glick
patent: 2004/0241781 (2004-12-01), Glick
patent: 2005/0113460 (2005-05-01), Glick
patent: 2005/0261176 (2005-11-01), Glick
patent: 2005/0272723 (2005-12-01), Glick
patent: 2006/0025388 (2006-02-01), Glick
patent: 2006/0052369 (2006-03-01), Glick
patent: 2006/0166975 (2006-07-01), Glick
patent: 2007/0036854 (2007-02-01), Glick
patent: 2007/0043033 (2007-02-01), Glick
patent: 2007/0105844 (2007-05-01), Glick
patent: 2007/0111994 (2007-05-01), Glick
patent: 2007/0135418 (2007-06-01), Glick et al.
patent: 2007/0299059 (2007-12-01), Glick
patent: 2008/0064686 (2008-03-01), Durrani
patent: 2372150 (2000-11-01), None
patent: 2457405 (2003-02-01), None
patent: 1810423 (1969-10-01), None
patent: 0349949 (1990-01-01), None
patent: 0227539 (1990-05-01), None
patent: 0349949 (1990-10-01), None
patent: 0 906 907 (1999-07-01), None
patent: 1143946 (2001-10-01), None
patent: 1423122 (2003-02-01), None
patent: 1398033 (2004-03-01), None
patent: 1398033 (2004-06-01), None
patent: 1622684 (2006-02-01), None
patent: 1742460 (2006-07-01), None
patent: 1778204 (2007-05-01), None
patent: 1786429 (2007-05-01), None
patent: 1845996 (2007-10-01), None
patent: 1363735 (1974-08-01), None
patent: 2096044 (1997-11-01), None
patent: 90/05305 (1990-05-01), None
patent: 90/13332 (1990-11-01), None
patent: 91/12779 (1991-09-01), None
patent: 9201683 (1992-02-01), None
patent: 94/08234 (1994-04-01), None
patent: 97/30992 (1997-08-01), None
patent: 98/14192 (1998-04-01), None
patent: 98/57161 (1998-12-01), None
patent: 99/19306 (1999-04-01), None
patent: 99/29347 (1999-06-01), None
patent: 99/58117 (1999-11-01), None
patent: 99/66958 (1999-12-01), None
patent: 99/67220 (1999-12-01), None
patent: 00/19200 (2000-06-01), None
patent: 00/66106 (2000-11-01), None
patent: 01/51922 (2001-07-01), None
patent: 02/67988 (2002-09-01), None
patent: 03/015703 (2003-02-01), None
patent: 03/041658 (2003-05-01), None
patent: 03/045901 (2003-06-01), None
patent: 03/050261 (2003-06-01), None
patent: 2008/133635 (2003-06-01), None
patent: 03/106628 (2003-12-01), None
patent: 2005/004988 (2005-01-01), None
patent: 2006/014526 (2006-02-01), None
patent: 2006/029245 (2006-03-01), None
patent: 2006/073448 (2006-07-01), None
patent: 2006/074358 (2006-07-01), None
patent: 2006/053193 (2007-05-01), None
patent: 2007/050587 (2007-05-01), None
patent: 2007/053725 (2007-05-01), None
patent: 2007/146167 (2007-12-01), None
patent: 2008/012553 (2008-09-01), None
patent: 2008/116156 (2008-09-01), None
patent: 2009/061916 (2009-05-01), None
AU Patent Application No. 2006203946 Examiner's Report dated Sep. 10, 2008.
EP Search, EP Patent Application No. 05856659.7 mailed Dec. 9, 2008.
Iiangumaran, et al., “CD44 Selectively Associates with Active Src Family Protein Tyrosine Kinases Lck and Lyn in Glycosphingolipid-Rich . . . ”, Blood, vol. 91, No. 10 (May 15, 1998), pp. 3901-3908.
Sato, et al., “CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor,” seminars in Immunology, vol. 10, 1998, pp. 287-297.
Joshi, et al., “Oligomycin Sensitivey-conferring Protein (OSCP) of Mitochodrial ATP Synthase,” The Journal of Biological Chemistry, vol. 267, No. 18,m Issue of Jun. 25, pp. 12860-12867, 1992.
Piedimonte, et al., “Association of Tyrosine Protein Kinase Activity With Mitochondria in Human Fibroblasts,” Journal of Cellular Biochemistry 32:113-123 (1986).
EP Search, EP Patent Application No. 04 775 923.8, dated Dec. 15, 2008.
Appleby, et al., “Murine chronic graft-versus-host disease as a model of osystemic lupus erythematosus: effect of immunosuppressive drugs on disease development,” Clin. Exp. Immunol. (1989) 78, 449-453.
Bastian, et al., “Casein Interference in Bovine Plasmin Assays Using a Synthetic Substrate,” (1991) J Dairy Sci 74:4119-4124.
Johnson, et al., “Mechanistic Basis for Therapeutic Targeting of the Mitochondrial FF-ATPase”, downloaded from http://pubs.acs.org on Dec. 5, 2008, ASC Chem. Biol. 1 (5), 304-308, Publication Date (WEB): Jun. 9, 2006.
Otto, Michael W., Ph.D., et al., “Benzodiazepine Use, Cognitive Impairment, and Cognitive-Behavioral Therapy for Anxiety Disorders: Issues in the Treatment of a Patient in Need,” J. Clin. Psychiatry, 2005, 66 (supp 2).
Yoshi, M., et al., (2005) Nippon Yakurigaku Zasshi 125(1):33-36 (English Abstract attached).
Yasuda, K., (2004) Nippon Rinsho. 62 Suppl. 12:360-363. Abstract not available.
Decaudin, Didier, “Peripheral benzodiazepine receptor and its clinical targeting,” Anti-Cancer Drugs, 2004, vol. 15, No. 8.
Bonnot, O., et al., “Exposition in utero au lorazepam et atresie anale: signal epidemiologique,” (2003) Encephale. 29 (6):553-559.
Lacapere, Jean-Jacques, Vassilios Papadopoulos, “Peripheral-type b
Casimir Jones SC
Kifle Bruck
The Regents of the University of Michigan
LandOfFree
Compositions and methods relating to novel compounds and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods relating to novel compounds and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods relating to novel compounds and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4151975